Fixed-dose combination of oxybutynin and pilocarpine is effective in treating hyperhidrosis March 7, 2017
Amryt completes phase III discussions with FDA and EMA for AP-101 in epidermolysis bullosa March 6, 2017
Immune Pharmaceuticals broadens enrollment criteria in bullous pemphigoid study of bertilimumab March 1, 2017
RSS